TY - JOUR
T1 - Is a functional sarcoplasmic reticulum necessary for preconditioning?
AU - Cave, A C
AU - Garlick, P B
PY - 2000
Y1 - 2000
N2 - Several studies have shown that the protective effect of ischemic preconditioning (PC) is associated with decreased calcium release from the sarcoplasmic reticulum (SR). However, no study has yet demonstrated whether these changes are essential in the mechanism of PC. In order to investigate whether a functional SR was necessary for PC, we manipulated SR calcium handling using (i) 0.1 mu M ryanodine (RY), a concentration known to lock the SR calcium release channel in the open state and (ii) 50 mu M cyclopiazonic acid (CPA), a specific inhibitor of the SR calcium ATPase. Initial experiments confirmed that both RY and CPA eliminated the ability of the SR to accumulate calcium. Isolated rat hearts (n = 6-7/group) were perfused normoxically for 30 min prior to either a further 40 min of perfusion [control (C)] or 4 x [5 min ischemia (I) + 5 min reperfusion JR)] (PC). All hearts were then subjected to a further 40 min I Jr 40 min R. The C and PC protocols were then repeated in the presence of RY or CPA, introduced after 10 min of perfusion. P-31-NMR was used to measure ATP, PCr, P-i and intracellular pH. RY and CPA decreased developed pressure (DP) by 75% and 59%, respectively. Percentage recovery of LVDP was significantly higher in PC (72 +/- 8%), PC + RY (72 +/- 7%) and PC + CPA (49 +/- 7%) groups compared with their respective controls (43 +/- 7%, 47 +/- 7% and 10 +/- 4%) (P
AB - Several studies have shown that the protective effect of ischemic preconditioning (PC) is associated with decreased calcium release from the sarcoplasmic reticulum (SR). However, no study has yet demonstrated whether these changes are essential in the mechanism of PC. In order to investigate whether a functional SR was necessary for PC, we manipulated SR calcium handling using (i) 0.1 mu M ryanodine (RY), a concentration known to lock the SR calcium release channel in the open state and (ii) 50 mu M cyclopiazonic acid (CPA), a specific inhibitor of the SR calcium ATPase. Initial experiments confirmed that both RY and CPA eliminated the ability of the SR to accumulate calcium. Isolated rat hearts (n = 6-7/group) were perfused normoxically for 30 min prior to either a further 40 min of perfusion [control (C)] or 4 x [5 min ischemia (I) + 5 min reperfusion JR)] (PC). All hearts were then subjected to a further 40 min I Jr 40 min R. The C and PC protocols were then repeated in the presence of RY or CPA, introduced after 10 min of perfusion. P-31-NMR was used to measure ATP, PCr, P-i and intracellular pH. RY and CPA decreased developed pressure (DP) by 75% and 59%, respectively. Percentage recovery of LVDP was significantly higher in PC (72 +/- 8%), PC + RY (72 +/- 7%) and PC + CPA (49 +/- 7%) groups compared with their respective controls (43 +/- 7%, 47 +/- 7% and 10 +/- 4%) (P
UR - http://www.scopus.com/inward/record.url?scp=0033849623&partnerID=8YFLogxK
U2 - 10.1006/jmcc.1999.1088
DO - 10.1006/jmcc.1999.1088
M3 - Article
SN - 1095-8584
VL - 32
SP - 415
EP - 427
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
IS - 3
ER -